Dr Lee is presently the Chief Executive Officer and Chief Scientist at Action Against Age-Related Macular Degeneration, a research charity focused on tackling the leading cause of legal blindness in the developed world at its earliest stages with maximum affordability and accessibility.
Previously Dr Lee directed the Disease Foundations Network at the Structural Genomics Consortium (SGC), based at the Nuffield Department of Clinical Medicine, University of Oxford. He is an experienced leader in setting up partnerships and alliances with multiple stakeholders to accelerate discoveries for drug discovery. Dr Lee designed and implemented several strategies in two of the largest and most successful international public-private partnerships for drug discovery – the Structural Genomics Consortium and the European Lead Factory. Alongside his scientific endeavours, Dr Lee also advised high-level government representatives from different countries and charitable institutions on policy and strategy to integrate scientific, societal and economic impact.
He is trained in Biology, Molecular and Structural Biology, Protein Crystallography, Computational Biology and Drug Discovery in diverse places such as Brazil (University of Campinas, Brazilian Synchrotron Source), USA (Scripps Research Institute) and France (Université Paris V).